TURNER WILLIAM D. (Chief Regulatory Officer) sold 30.8% of their position (10K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $400.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001193125-25-308074
Officer· Chief Regulatory Officer
Since Feb 2026
-10K
Net shares
Net seller
$400.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+10K
Price / share
$15.53
Trade value
$155.30K
% of position
44.4%
12/3/2025
22.50K→32.50K
Class A Common Stock
Direct
Shares
−10K
Price / share
$40.00
Trade value
$400K
% of position
30.8%
12/3/2025
32.50K→22.50K
Total
Net shares
+0.00
Net value
-$244.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/3/2025 | M · Option Exercise | +10K | $15.53 | $155.30K | 44.4% | 22.50K | 32.50K |
| Class A Common Stock Direct | 12/3/2025 | S · Sale | −10K | $40.00 | $400K | 30.8% | 32.50K | 22.50K |
| Total | +0.00 | -$244.70K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
10K shares
Shares
−10K
Strike price
15.53
Held after
265K
Exercisable
—
12/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock10K shares | 12/3/2025 | M · Option Exercise | −10K | 15.53 | — | 265K |